SVS Clinical Research Seed Grants
| 2009-10 Award Winners |
|
Dr. Rajeev Dayal Columbia University
Dr. Eugene Lee University of California-Davis
Dr. Brian Nolan Dartmouth Hitchcock Medical Center |
| 2008 Award Winners |
|
Dr. Fritz Bech Palo Alto Institute of Research & Education
Dr. Oscar Grandas & Dr. David Cassada University of Tennessee Graduate School of Medicine
Dr. Rabih Chaer University of Pittsburgh |
| 2007 Award Winners |
|
Dr. Greg Landry Oregon Health and Science University
Dr. Maureen Sheehan University of Texas San Antonio
Dr. Mark Wyers Dartmouth Hitchcock Medical Center |
In recognition of the growing importance of clinical investigation in vascular disease, SVS announces the Clinical Research Seed Grant program.
Purpose: It is vitally important, both to patients and to the specialty, that vascular surgeons play prominent roles in both industry and investigator-initiated clinical trials. The Clinical Research Seed Grant program has the following goals:
- Encourage the interest and development of clinical investigators among the SVS membership, particularly junior members or those with limited prior experience as Principal Investigators
- Provide direct support for pilot clinical projects that have potential to develop into larger studies fundable by industry or governmental sources
Scope: Clinical research, preferably patient-oriented (NIH defines patient-oriented research as research conducted with human subjects or on material of human origin such as tissues, specimens and cognitive phenomena for which an investigator directly interacts with human subjects). Small-scale clinical trials and ancillary studies in the setting of existing clinical trials (industry or NIH-supported) are particularly encouraged. Relevant examples include:
- Ancillary studies coupled to existing clinical trials. Possible examples include studies to develop/test biomarkers, surrogate imaging, and studies of physiologic, or quality of life endpoints. A letter of support from the primary trial sponsor is required
- Pilot clinical trials of any type
- Studies on the natural history of vascular disease, pathophysiology, or mechanisms underlying success or failure of vascular interventions
- Application of quality-of-life, functional status, and resource utilization measures to assess the impact of vascular interventions
- Development and validation of clinical risk-prediction models or diagnostic tools
- Studies addressing the nature of disparities in care and outcomes
Contact: Society for Vascular Surgery, 312-334-2305 or vascular@vascularsociety.org